BlackRock’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-679,323
Closed -$3.34M 5830
2021
Q3
$3.34M Sell
679,323
-4,016
-0.6% -$19.7K ﹤0.01% 4046
2021
Q2
$3.61M Buy
683,339
+134,329
+24% +$709K ﹤0.01% 3949
2021
Q1
$2.64M Buy
549,010
+14,097
+3% +$67.7K ﹤0.01% 4137
2020
Q4
$2.32M Buy
534,913
+3,994
+0.8% +$17.3K ﹤0.01% 3914
2020
Q3
$2.19M Sell
530,919
-67,151
-11% -$277K ﹤0.01% 3785
2020
Q2
$1.53M Sell
598,070
-1,182,408
-66% -$3.03M ﹤0.01% 3825
2020
Q1
$5.15M Buy
1,780,478
+45,169
+3% +$131K ﹤0.01% 3288
2019
Q4
$6.58M Sell
1,735,309
-480,867
-22% -$1.82M ﹤0.01% 3381
2019
Q3
$11.3M Buy
2,216,176
+21,088
+1% +$108K ﹤0.01% 3112
2019
Q2
$13.6M Buy
2,195,088
+112,278
+5% +$696K ﹤0.01% 3031
2019
Q1
$14.8M Buy
2,082,810
+18,052
+0.9% +$128K ﹤0.01% 2893
2018
Q4
$17.6M Buy
2,064,758
+174,844
+9% +$1.49M ﹤0.01% 2783
2018
Q3
$37.8M Buy
1,889,914
+43,818
+2% +$877K ﹤0.01% 2514
2018
Q2
$47.7M Buy
1,846,096
+361,303
+24% +$9.33M ﹤0.01% 2366
2018
Q1
$35.5M Buy
1,484,793
+139,385
+10% +$3.33M ﹤0.01% 2459
2017
Q4
$45.6M Sell
1,345,408
-9,563
-0.7% -$324K ﹤0.01% 2332
2017
Q3
$28.7M Buy
1,354,971
+165,930
+14% +$3.51M ﹤0.01% 2582
2017
Q2
$20.8M Sell
1,189,041
-111,388
-9% -$1.95M ﹤0.01% 2745
2017
Q1
$22.8M Buy
1,300,429
+1,297,729
+48,064% +$22.7M ﹤0.01% 2660
2016
Q4
$46K Sell
2,700
-219
-8% -$3.73K ﹤0.01% 2919
2016
Q3
$48K Sell
2,919
-945
-24% -$15.5K ﹤0.01% 2920
2016
Q2
$59K Buy
3,864
+3,102
+407% +$47.4K ﹤0.01% 2816
2016
Q1
$11K Buy
762
+459
+151% +$6.63K ﹤0.01% 3077
2015
Q4
$9K Hold
303
﹤0.01% 2916
2015
Q3
$5K Hold
303
﹤0.01% 3009
2015
Q2
$8K Buy
+303
New +$8K ﹤0.01% 2892
2014
Q4
Sell
-21,100
Closed -$393K 3151
2014
Q3
$393K Sell
21,100
-1,700
-7% -$31.7K ﹤0.01% 1356
2014
Q2
$417K Buy
+22,800
New +$417K ﹤0.01% 1333